| Literature DB >> 35831426 |
Atefeh Mazlumi1, Bahman Panahi2, Mohammad Amin Hejazi3, Yousef Nami4.
Abstract
This research aimed to isolate lactic acid bacteria from the bowel of saltwater fish to assess their potential probiotic properties. Nineteen isolates of LAB including Lactiplantibacillus plantarum, Lactiplantibacillus pentosus, Lactobacillus acidophilus, Levilactobacillus brevis, Pediococcus pentosaceus, and Pediococcus acidilactici were recognized using molecular tools. All the isolates survived in the simulated conditions of the GI tract. Auto-aggregation ranged from 01.3 ± 0.5 to 82.6 ± 1.4% and hydrophobicity with toluene ranged from 3.7 ± 1.6 to 69.4 ± 1.3%, while the range of hydrophobicity with xylene was from 02.2 ± 1.6 to 56.4 ± 2.1%. All the isolates of lactobacilli, pediococci, enterococci, and lactococci indicated variable sensitivity and resistance towards clinical antibiotics. Non-neutralized cell free supernatant of isolates F12 and F15 showed antimicrobial activity against all the 8 evaluated enteric pathogens. Cluster analysis of identified potential probiotic bacteria based on heat-map and PCA methods also highlighted the priority of isolates F3, F7, F12, and F15 as bio-control agents in fishery industry. The findings of this study may essentially contribute to the understanding of the probiotic potential of LAB in saltwater fish, in order to access their probiotic characterization for use as biocontrol in fishery.Entities:
Mesh:
Year: 2022 PMID: 35831426 PMCID: PMC9279464 DOI: 10.1038/s41598-022-16322-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Zone inhibition (mm) of antimicrobial properties of isolates.
| Isolates | Indicator bacteria | |||||||
|---|---|---|---|---|---|---|---|---|
| F1 | 0 | 17 | 14 | 17 | 19 | 0 | 21 | 22 |
| F2 | 8 | 0 | 21 | 20 | 0 | 17 | 19 | 13 |
| F3 | 14 | 18 | 10 | 0 | 16 | 13 | 22 | 20 |
| F4 | 0 | 15 | 17 | 9 | 21 | 16 | 16 | 19 |
| F5 | 16 | 0 | 11 | 12 | 9 | 18 | 13 | 14 |
| F6 | 11 | 13 | 20 | 8 | 0 | 21 | 17 | 14 |
| F7 | 22 | 21 | 19 | 0 | 12 | 0 | 10 | 18 |
| F8 | 13 | 11 | 11 | 11 | 17 | 12 | 18 | 0 |
| F9 | 0 | 0 | 16 | 15 | 19 | 9 | 22 | 14 |
| F10 | 9 | 10 | 14 | 0 | 0 | 8 | 15 | 21 |
| F11 | 0 | 0 | 22 | 0 | 0 | 0 | 24 | 0 |
| F12 | 19 | 22 | 28 | 23 | 19 | 21 | 31 | 26 |
| F13 | 8 | 9 | 12 | 0 | 12 | 15 | 16 | 0 |
| F14 | 0 | 0 | 20 | 0 | 0 | 0 | 19 | 0 |
| F15 | 21 | 19 | 26 | 22 | 17 | 14 | 29 | 25 |
| F16 | 0 | 7 | 16 | 19 | 8 | 19 | 19 | 18 |
| F17 | 14 | 11 | 19 | 10 | 0 | 16 | 21 | 12 |
| F18 | 0 | 0 | 24 | 0 | 0 | 0 | 17 | 0 |
| F19 | 12 | 8 | 21 | 17 | 18 | 0 | 12 | 0 |
Antibiotic susceptibility profile of isolates.
| Isolates | Antibiotics | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ampicillin (10 µg) | Vancomycin (30 µg) | Erythromycin (15 µg) | Azithromycin (15 µg) | Gentamycin (10 µg) | Penicillin (10 µg) | Chloramphenicol (30 µg) | Tetracycline (30 µg) | Streptomycin (10 µg) | Ciprofloxacin (5 µg) | |
| F1 | I | R | S | R | I | R | S | S | S | I |
| F2 | R | I | R | I | I | I | S | S | R | R |
| F3 | S | S | S | S | S | S | S | S | S | S |
| F4 | S | R | I | I | R | R | R | I | R | I |
| F5 | S | I | S | R | R | R | S | S | I | R |
| F6 | S | R | S | I | R | R | S | I | R | I |
| F7 | S | S | S | S | S | S | S | S | S | S |
| F8 | S | R | S | R | S | I | S | S | I | R |
| F9 | S | I | S | R | R | R | S | S | R | I |
| F10 | S | S | S | S | R | S | S | S | R | R |
| F11 | R | R | I | R | R | R | S | S | I | R |
| F12 | S | S | S | S | S | S | S | S | S | S |
| F13 | S | R | S | S | R | R | S | S | R | R |
| F14 | S | I | S | R | R | R | S | S | I | R |
| F15 | S | S | S | S | S | S | S | S | S | S |
| F16 | I | R | S | R | I | R | S | S | R | R |
| F17 | S | I | R | R | R | R | S | I | S | R |
| F18 | R | R | R | R | R | R | R | R | R | R |
| F19 | S | R | S | S | R | S | S | S | I | R |
I: intermediate susceptibility (zone diameter 12.5–17.4 mm); R: resistant (zone diameter < 12.4 mm); S: susceptible (zone diameter > 17.5).
Figure 1Gram-staining test (A) and the quality and size of 16S-rRNA gene (1544 bp) amplified by a pair of primers (Hal-6F and Hal-R6). 1 kb ladder was used (B).
Figure 2Tolerance of isolates to low pH and high bile salt concentrations.
Hydrophobicity, adhesion ability and cholesterol assimilation capacity of selected strains.
| Isolates | LAB species | Hydrophobicity (%) | Auto-aggregation (%) | Co-aggregation (%) | Adhesion ability (%) | Cholesterol assimilation (%) | ||
|---|---|---|---|---|---|---|---|---|
| Toluene | Xylene | |||||||
| F1 | 30.2 ± 1.8 cd | 29.1 ± 1.6f. | 24.6 ± 1.5i | 27.3 ± 1.7i | 25.1 ± 1.6f. | 0 | 19.2 ± 1.1 k | |
| F2 | 34.9 ± 1.6c | 34.2 ± 1.7e | 28.4 ± 1.7 h | 30.4 ± 2.1gh | 29.4 ± 1.7e | 0 | 23.9 ± 1.6j | |
| F3 | 69.4 ± 1.3a | 65.6 ± 1.9d | 75.6 ± 1.9b | 52.4 ± 2.3c | 61.2 ± 2.2a | 24.7 ± 1.7 | 64.5 ± 1.8b | |
| F4 | 30.4 ± 2.1 cd | 28.8 ± 1.7 fg | 31.4 ± 1.7f. | 36.4 ± 1.9e | 33.8 ± 1.4d | 0 | 52.1 ± 1.8d | |
| F5 | 28.4 ± 1.6 cd | 27.3 ± 1.5gh | 33.4 ± 1.9e | 29.7 ± 1.7 h | 28.9 ± 2.1e | 0 | 37.4 ± 1.9 g | |
| F6 | 25.7 ± 1.8 cd | 23.5 ± 1.2i | 29.7 ± 2.2gh | 19.4 ± 1.3j | 17.5 ± 1.6i | 0 | 33.5 ± 2.1 h | |
| F7 | 66.1 ± 1.3a | 72.3 ± 1.7b | 82.6 ± 1.4a | 55.3 ± 2.1b | 49.7 ± 1.8c | 27.5 ± 1.9 | 59.7 ± 2.2c | |
| F8 | 26.3 ± 2.1 cd | 23.6 ± 1.5i | 20.4 ± 1.2j | 16.2 ± 1.7 k | 14.9 ± 1.5j | 31.4 ± 2.1 | 31.2 ± 2.1i | |
| F9 | 27.1 ± 1.4 cd | 25.8 ± 2.1 h | 36.2 ± 2.3d | 31.5 ± 1.9 fg | 33.8 ± 1.4d | 0 | 22.5 ± 0.9j | |
| F10 | 30.1 ± 1.9 cd | 29.8 ± 2.0f. | 31.2 ± 2.1 fg | 27.7 ± 1.5i | 26.8 ± 1.4e | 0 | 37.2 ± 1.8 g | |
| F11 | 04.9 ± 1.1 g | 02.2 ± 1.6n | 04.3 ± 1.4 m | 08.6 ± 1.4i | 03.2 ± 1.6 m | 0 | 11.8 ± 0.9 l | |
| F12 | 66.8 ± 1.8b | 76.4 ± 2.1a | 73.8 ± 2.3c | 58.3 ± 1.8a | 53.4 ± 2.2b | 38.7 ± 1.5 | 78.2 ± 1.9a | |
| F13 | 10.2 ± 1.4 fg | 08.4 ± 1.3 l | 10.4 ± 1.6 k | 02.9 ± 1.4 m | 09.4 ± 1.5 k | 0 | 42.8 ± 2.6f. | |
| F14 | 22.9 ± 1.7de | 22.7 ± 1.5i | 25.7 ± 1.8i | 20.3 ± 1.6j | 21.2 ± 1.9 g | 0 | 47.2 ± 2.2e | |
| F15 | 70.2 ± 2.0a | 68.2 ± 1.9c | 72.4 ± 2.3c | 42.1 ± 1.2d | 35.5 ± 1.4d | 23.2 ± 1.5 | 30.7 ± 1.7i | |
| F16 | 14.4 ± 1.8ef | 13.7 ± 1.4j | 18.9 ± 1.7j | 15.5 ± 1.6 k | 18.2 ± 1.9 h | 0 | 33.4 ± 1.9 h | |
| F17 | 29.1 ± 1.5 cd | 28.2 ± 1.9 fg | 35.7 ± 1.4d | 32.2 ± 2.3 fg | 27.5 ± 1.1ef | 0 | 29.8 ± 2.5i | |
| F18 | 03.7 ± 1.6 g | 05.9 ± 1.1 m | 08.1 ± 1.7 l | 02.5 ± 1.2 m | 05.5 ± 1.6 l | 0 | 03.6 ± 1.2n | |
| F19 | 11.4 ± 1.8 fg | 10.6 ± 1.8 k | 01.3 ± 0.5n | 03.8 ± 1.8 m | 01.4 ± 0.9n | 0 | 7.25 ± 1.3 m | |
Values are mean ± standard error.
a–nValues followed by the same letters are not significantly different (P > 0.05). Statistical analysis of each formulation was done separately.
Figure 3Biofilm formation ability of selected strains. Bars represent standard errors of the mean (n = 3). Based on the OD, bacteria were classified as non-biofilm producers (OD ≤ ODC), weak (ODC < OD ≤ 2 × ODC), moderate (2 × ODC < OD ≤ 4 × ODC) or strong biofilm producers (4 × ODC < OD; Borges et al., 2012). Where the cut-off (ODC) was defined as the mean OD value of the negative control.
Figure 4Cluster analysis of isolates based on probiotic characteristics using heat-map (A) and PCA (B) methods.